1.Wade, JC, Newman, KA, Schimpff, SC, et al.Two methods for improved venous access in acute leukemia patients. JAMA 1981;246:140–144.
2.Rubenstein, EB, Fender, A, Rolston, KVT, et al.Vascular access by physician assistants: evaluation of an implantable peripheral port system in cancer patients. J Clin Oncol 1995;13:1513–1519.
3.Sotir, MJ, Lewis, C, Bisher, EW, Ray, SM, Soicie, JM, Blumberg, HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 1999;20: 187–191.
4.Prospero, E, Barbadoro, P, Savini, S, Manso, E, Annino, I, D'Errico, MM. Cluster of Pseudomonas aeruginosa catheter-related bloodstreams infections traced to contaminated multidose heparinized saline solutions in a medical ward. Int J Hyg Environ Health 2006;209:553–556.
5.Hsueh, PR, Teng, LJ, Pan, HJ, et al.Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol 1998;36:2914–2917.
6.Torii, K, Nöda, Y, Miyazaki, Y, Ohta, M. An unusual outbreak of infusion-related bacteremia in a gastrointestinal disease ward. Jpn J Infect Dis 2003;56:177–178.
7.Kimura, AC, Calvet, H, Higa, JI, et al.Outbreak of Ralstonia pickettii bacteremia in a neonatal intensive care unit. Pediatr Infect Dis J 2005;24:1099–1103.
8.Perz, JF, Craig, AS, Strattin, CW, Bodner, SJ, Phillips, WE Jr, Schaffner, W. Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy. J Clin Microbiol 2005;43:5316–5318.
9.Centers for Disease Control and Prevention. Pseudomonas bloodstream infections associated with a heparin/saline flush—Missouri, New York, Texas, and Michigan, 2004-2005. MMWR Morb Mortal Wkly Rep 2005;54:269–272.
10.Albo Lopez, C, Lopez Rodriguez, D, Constenla Camba, MI, Jimenez Blanco, A, Araujo, LF, Garcia-Medina, J. Infectious and non-infectious complications of tunneled central catheters in hematologic patients [in Spanish]. Sangre (Bare) 1999;44:176–181.
11.Biffi, R, de Braud, F, Orsi, F, et al.Totally implantable central venous access ports for long-term chemotherapy: a prospective study analyzing complications and cost of 333 devices with a minimum follow-up of 180 days. Ann Oncol 1998;9:767–773.
12.National Committee for Clinical Laboratory Standards (NCCLS). Reference Standards for Antimicrobial Susceptibility Testing. Wayne, PA: NCCLS; 2002:M100–59.
13.Sambrook, J, Fritsch, EF, Maniatis, T. Molecular Cloning, a Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
14.Renders, N, Romling, Y, Verbrugh, H, Van Belkum, A. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J Clin Microbiol 1996;34:3190–3195.
15.Tenover, F, Arbeit, R, Goering, R, et al.Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.
16.Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy—United States, July-November 2002. MMWR Morb Mortal Wkly Rep 2002;51:1109–1112.
17.Aumeran, C, Paillard, C, Robin, F, et al.Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J Hosp Infect 2007;65:47–53.
18.Romney, M, Sherlock, C, Stephens, G, Clarke, A. Pseudo-outbreak of Pseudomonas putida in a hospital outpatient clinic originating from a contaminated commercial anti-fog solution— Vancouver, British Columbia. Can Commun Dis Rep 2000;26:183–184.
20.Valdezate, S, Vindel, A, Martin-Davila, P, Del Saz, BS, Baquero, F, Canton, R. High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. J Clin Microbiol 2004;42: 693–699.
21.Klausner, JD, Zukerman, C, Limaye, AP, Corey, L. Outbreak of Stenotrophomonas maltophilia bacteremia among patients undergoing bone marrow transplantation: association with faulty replacement of handwashing soap. Infect Control Hosp Epidemiol 1999;20:756–758.
22.Gulcan, H, Kuzuku, C, Durmaz, R. Nosocomial Stenotrophomonas maltophilia cross-infection: three cases in newborns. Am J Infect Control 2004;32: 365–368.
23.Sakhnini, E, Weissmann, A, Oren, I. Fulminant Stenotrophomonas maltophilia soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water. Am J Med Sci 2002;323: 269–272.
24.Verweij, PE, Meis, JF, Christmann, V, et al.Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water. Epidemiol Infect 1998;120:251–256.
25.Weber, DJ, Rutala, WA, Blanchet, CN, Jordan, M, Gergen, MF. Faucet aerators: a source of patient colonization with Stenotrophomonas maltophilia. Am J Infect Control 1999;27:59–63.
26.Rogues, AM, Maugein, J, Allery, A, et al.Electronic ventilator temperature sensors as a potential source of respiratory tract colonization with Stenotrophomonas maltophilia. J Hosp Infect 2001;49:289–292.
27.Labarca, JA, Leber, AL, Kern, VL, et al.Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 2000;30:195–197.
28.Alfieri, N, Ramotar, K, Armstrong, P, Spornitz, ME, Ross, G, Winnick, J, Cook, DR. Two consecutive outbreaks of Stenotrophomonas maltophilia (Xanthomonas maltophilia) in an intensive-care unit defined by restriction fragment-length polymorphism typing. Infect Control Hosp Epidemiol 1999;20:553–556.
29.Hanna, H, Afif, C, Alakech, B, et al.Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 2004;25:646–649.
30.Fatkenheuer, G, Comely, O, Seifert, H. Clinical management of catheter-related infections. Clin Microbiol Infect 2002;8: 545–550.
31.Lee, MY, Ko, KS, Song, JH, Peck, KR. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother 2007;60:782–787.
32.Ma, Q, Zhai, Y, Schneider, JC, Ramseier, TM, Saier, MH. Protein secretion systems of Pseudomonas aeruginosa and P. fluorescens. Biochim Biophys Acta 2003;1611: 223–233.